Logo for Shattuck Labs Inc

Shattuck Labs Inc Investor Relations Material

Latest events

Logo for Shattuck Labs Inc

Study Update

Shattuck Labs Inc
Logo for Shattuck Labs Inc

Corporate Presentation

29 Feb, 2024
Logo for Shattuck Labs Inc

Q4 2023

29 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Shattuck Labs Inc

Access all reports
Shattuck Labs is a clinical-stage biotechnology company developing therapeutics for the treatment of cancer and autoimmune disease. The company was incorporated in 2016, and is focused on developing SL-172154 for the treatment of ovarian, fallopian tube and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma.